COMMUNIQUÉS West-GlobeNewswire

-
ASLAN Pharmaceuticals Granted Orphan Drug Designation by the FDA for ASLAN003 for the Treatment of Acute Myeloid Leukaemia
20/08/2018 -
Olainfarm Group seven-month sales increase by 4%.
20/08/2018 -
Immunocore Announces Start of Phase I ImmTAC® Study in Patients with Solid Tumours
20/08/2018 -
Sensorion Receives European Authorization to Initiate SENS-401 Phase 2 Trial in Sudden Sensorineural Hearing Loss
20/08/2018 -
Assure Holdings Reports First Quarter 2018 Financial Results
18/08/2018 -
Coherus BioSciences Announces New Employment Inducement Grants
17/08/2018 -
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
17/08/2018 -
Pain Therapeutics Announces Closing of $11.3 Million Registered Direct Offering
17/08/2018 -
Kalytera Announces Further Payments in Shares under Payments Agreements with Salzman Group
17/08/2018 -
CORRECTION - Agility Health Announces Private Placement, Engages Frontier Flex Marketing and Grants Stock Options
17/08/2018 -
BioSig Technologies Closes Private Placement
17/08/2018 -
Syneos Health to Present at the 2018 Baird Global Healthcare Conference
17/08/2018 -
BioStem Technologies, Inc. Completes 2016, 2017 Audit of Financial Statements
17/08/2018 -
Golden Leaf Holdings Announces Acquisition of Combined Cultivation, Production and Retail License in California
17/08/2018 -
American Pain Association President Selects Tree of Knowledge as CBD Supplier -- CFN Media
17/08/2018 -
Welldoc® to Highlight Adoption of Digital Therapeutics for Improving Diabetes Care with Five Poster Presentations at AADE 2018 Annual Meeting
17/08/2018 -
Mateon Therapeutics Receives Notice of Partial Clinical Hold for OX1222 Study
17/08/2018 -
Navamedic ASA: Invitation to presentation of second quarter 2018
17/08/2018 -
VPR Brands, LP Announces Second Quarter 2018 Results
17/08/2018
Pages